Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon

  title={Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon},
  author={Rainer Ehmann and Enole Boedeker and U Friedrich and Jutta Sagert and J{\"u}rgen Dippon and Godehard Friedel and Thorsten Walles},
  journal={European Respiratory Journal},
  pages={669 - 676}
Patient prognosis in lung cancer largely depends on early diagnosis. The exhaled breath of patients may represent the ideal specimen for future lung cancer screening. However, the clinical applicability of current diagnostic sensor technologies based on signal pattern analysis remains incalculable due to their inability to identify a clear target. To test the robustness of the presence of a so far unknown volatile organic compound in the breath of patients with lung cancer, sniffer dogs were… 

Canine scent detection for the diagnosis of lung cancer in a screening-like situation

The results differed from those of previous studies, indicating that canine scent detection might not be as powerful as is looked for in real screening situations, and one main reason for the rather poor performance in the setting might be the higher stress from the lack of positive responses for dogs and handlers.

Can dogs smell lung cancer? First study using exhaled breath and urine screening in unselected patients with suspected lung cancer

Although the olfactory test appears to be a promising tool for the detection of cancer, the main challenge is to determine whether the test can sufficiently discriminate between patients at risk, patients with benign disease, and patients with malignant disease.

Accuracy of Canine Scent Detection of Non–Small Cell Lung Cancer in Blood Serum

The findings of this study provide a starting point for a larger-scale research project designed to explore the use of canine scent detection as a tool for cancer biomarkers.

Lung cancer detection by canine scent: will there be a lab in the lab?

The high accuracy of canine scent detection of lung cancer suggests dogs might, in the future, make some modest contribution to successes in lung cancer screening and detection.

Sniffer dogs can identify lung cancer patients from breath and urine samples

It is concluded that olfactory detection of lung cancer by specifically trained dogs is highly suggestive to be a simple and non-invasive tool to detect lung cancer.

Smell, Lung Cancer, Electronic Nose and Trained Dogs

The feasibility of three strategies, and the possible synergic effect of their concomitant application as a powerful pre-estimation tool for mass-screening of LC high-risk population.

Comment on Canine scent detection for the diagnosis of lung cancer in a screening-like situation

There are a number of methodological issues with the study that makes it difficult to draw accurate conclusions regarding the suitability of dogs for use in olfactory detection of human illness, and specifically as set out in the Hackner study for cancer screening.

The detection of hepatocellular carcinoma (HCC) from patients’ breath using canine scent detection: a proof-of-concept study

This is the first study to look at the possibility of detecting HCC from breath using canine olfaction and shows that this is possible with an accuracy of 78% (p < 0.001 when compared to chance alone), and are thus a proof of concept.

Canine Scent Detection of Lung Cancer : Preliminary Results

If dogs can discriminate lung cancer not only from healthy subjects, but also from patients with other lung diseases, it is believed that, in the future, dogs may be used to perform early diagnostic tests, useful in improving the chances of survival in cases of human lung cancer.



Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers

Training was efficient and cancer identification was accurate; in a matter of weeks, ordinary household dogs with only basic behavioral “puppy training” were trained to accurately distinguish breath samples of lung and breast cancer patients from those of controls.

Detection of lung cancer by sensor array analyses of exhaled breath.

The exhaled breath of patients with lung cancer has distinct characteristics that can be identified with an electronic nose, and the results provide feasibility to the concept of using the electronic nose for managing and detecting lung cancer.

Exhaled biomarkers in lung cancer

The scientific evidence demonstrating that a unique chemical signature can be detected in the breath of patients with lung cancer and that the exhaled breath biomarker profile could aid clinical decision making is reviewed.

An investigation on electronic nose diagnosis of lung cancer.

Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors

The results showed that the nanosensor array could differentiate between ‘healthy’ and ‘cancerous’ breath, and between the breath of patients having different cancer types, and could lead to the development of an inexpensive, easy-to-use, portable, non-invasive tool that overcomes many of the deficiencies associated with the currently available diagnostic methods for cancer.

The use of canines in the detection of human cancers.

Although this study did not produce the outcomes desired, the literature supports a potential to use canines for human cancer detection, and better management of urine samples and a more stringent training protocol during the study may have provided new evidence.

Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.

The findings demonstrate that certain compounds can be cancer cell derived and thus may be indicative of the presence of a tumor.

Current concepts on the role of inflammation in COPD and lung cancer.

Smoking Cessation: An Integral Part of Lung Cancer Treatment

Given the significant benefits of smoking cessation and that tobacco dependence remains a challenge for many lung cancer patients, cancer care providers need to offer full support and intensive treatment with a smoking cessation program that is tailored to lung cancer Patients’ specific needs.